Breaking News Instant updates and real-time market news.

DHR

Danaher

$104.00

5.2 (5.26%)

, WMB

Williams

$28.47

0.7 (2.52%)

09:55
07/19/18
07/19
09:55
07/19/18
09:55

Early notable gainers among liquid option names on July 19th

Notable gainers among liquid option names this morning include Danaher (DHR) $104.48 +5.69, Williams (WMB) $28.83 +1.06, IBM (IBM) $149.77 +5.35, Comcast (CMCSA) $35.16 +1.13, and Dover (DOV) $76.41 +2.22.

DHR

Danaher

$104.00

5.2 (5.26%)

WMB

Williams

$28.47

0.7 (2.52%)

IBM

IBM

$149.81

5.37 (3.72%)

CMCSA

Comcast

$34.93

0.9 (2.64%)

DOV

Dover

$75.88

1.67 (2.25%)

  • 19

    Jul

  • 19

    Jul

  • 26

    Jul

  • 06

    Aug

DHR Danaher
$104.00

5.2 (5.26%)

01/31/18
FBCO
01/31/18
NO CHANGE
Target $105
FBCO
Outperform
Danaher price target raised to $105 from $99 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Danaher to $105 from $99 on heightened conviction in his above-consensus 2018 EPS estimate of $4.36, reflecting continuing momentum in core revenue growth and accompanying profit margin leverage. The analyst reiterates an Outperform rating on the shares.
06/28/18
JPMS
06/28/18
DOWNGRADE
Target $105
JPMS
Underweight
JPMorgan downgrades Varian to Underweight following period of restriction
JPMorgan analyst Tycho Peterson downgraded Varian Medical Systems (VAR) to Underweight from Neutral following a period of restriction. Persistent order growth volatility, a "sluggish" end market and in the near-term and risk from the U.S.-China trade war weigh on the analyst's longer-term outlook for the stock. Varian has a dominant franchise but a mature industry and premium valuation are hard to overlook, Peterson tells investors in a research note. The analyst sees better risk/rewards in other parts of his coverage universe, including tool names Agilent (A), Danaher (DHR) and Thermo Fisher (TMO).
02/15/18
LEHM
02/15/18
INITIATION
Target $110
LEHM
Overweight
Danaher initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Danaher with an Overweight rating and $110 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/01/18
ARGS
02/01/18
NO CHANGE
Target $115
ARGS
Buy
Danaher price target raised to $115 from $100 at Argus
Argus analyst John Eade raised his price target on Danaher to $115 from $100 and kept his Buy rating after a Q4 earnings beat. Eade says that based on the company's history of double-digit dividend growth, he anticipates the management to announce another increase in the payout in the coming weeks.
WMB Williams
$28.47

0.7 (2.52%)

05/18/18
05/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PayPal (PYPL) assumed with a Buy from Neutral at UBS with analyst Eric Wasserstrom saying PayPal will benefit from sustained volume growth given the growing engagement from merchants and consumers. 2. Yelp (YELP) upgraded to Buy from Neutral at B. Riley FBR with analyst Sameet Sinha saying the company's opportunity in Request-a-Quote should drive a multiyear acceleration in revenue. 3. Marriott (MAR) and Host Hotels (HST) were upgraded to Outperform from In Line at Evercore ISI while Hilton (HLT) and Sunstone Hotel (SHO) were upgraded to In Line from Underperform. 4. Eaton (ETN) upgraded to Buy from Neutral at BofA/Merrill with analyst Andrew Obin saying he is more constructive on Eaton's core growth given the solid industrial macro backdrop, and improved visibility on Electrical Systems & Services segment growth. 5. Williams (WMB) upgraded to Outperform from Sector Perform at Scotiabank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/18
JEFF
07/18/18
NO CHANGE
Target $34
JEFF
Buy
Jefferies replaces Oneok with Williams on Franchise Pick List
Jefferies analyst Christopher Sighinolfi replaced Oneok (OKE), a stock he downgraded this morning, with Williams (WMB) on his firm's Franchise Pick List. The analyst has a Buy rating on Williams with a $34 price target.
05/21/18
STFL
05/21/18
DOWNGRADE
STFL
Hold
Williams Partners downgraded to Hold from Buy at Stifel
Stifel analyst Selman Akyol downgraded Williams Partners (WPZ) to Hold from Buy to reflect the announcement of a rollup into Williams Companies (WMB).
05/18/18
SCOT
05/18/18
UPGRADE
SCOT
Outperform
Williams upgraded to Outperform from Sector Perform at Scotiabank
IBM IBM
$149.81

5.37 (3.72%)

07/19/18
DBAB
07/19/18
NO CHANGE
Target $150
DBAB
Hold
IBM price target lowered to $150 from $160 at Deutsche Bank
Deutsche Bank analyst Sherri Scribner lowered her price target for IBM to $150 and keeps a Hold rating on the shares. IBM last night reported Q2 sales and earnings numbers that came in slightly ahead of Street estimates, but the beat was primarily driven by the benefit of the mainframe cycle, Scribner tells investors in a research note. Performance in IBM's other three businesses were "more mixed," with sales ex-hardware not growing year-over-year in constant currency, the analyst adds. She views the stock's risk/reward as balanced at current levels.
07/19/18
BMOC
07/19/18
NO CHANGE
Target $172
BMOC
IBM Q2 Cognitive segment results 'disappointing', says BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on IBM to $172 from $175 and kept his Market Perform rating after its Q2 results. The analyst notes that while the company saw some progress on the services side and the Systems performance was better than expected, the Cognitive segment results were disappointing, particularly given that the business contains high-growth Watson and blockchain offerings. Bachman adds that the latest update on Cognitive segment is raising questions on whether IBM can sustain meaningful growth in operating income and free cash flows.
07/19/18
STFL
07/19/18
NO CHANGE
Target $178
STFL
Buy
IBM report included reasons to be more optimistic, says Stifel
Stifel analyst David Grossman noted that IBM's Services revenue continued to improve in Q2 and he sees the turnaround in Services being the primary catalyst to drive IBM estimates and the stock's multiple higher over the next 12 months. While some have questioned the sustainability of revenue momentum and margin expansion, Grossman believes the market is overlooking tailwinds from restructuring actions he sees yielding about 150bp of margin tailwind in the second half and leverage from Services growth. He trimmed his price target to $178 from $182 and keeps a Buy rating on IBM shares.
07/19/18
MSCO
07/19/18
NO CHANGE
Target $185
MSCO
Overweight
IBM 'relatively clean' Q2 beat puts floor under valuation, says Morgan Stanley
Morgan Stanley analyst Katy Huberty said IBM's report of a "relatively clean" beat in Q2 builds hope that the company's transformation is playing out and helps put a floor under the stock's valuation. The quarter "wasn't without blemishes," said Huberty, who pointed to cognitive revenue declines and gross margins struggling to stabilize, but another clean quarter in September could help the stock re-rate more meaningfully, she believes. Based on recent peer multiple compression, Huberty lowered her multiple for IBM and cut her price target to $185 from $198, but she keeps an Overweight rating on the shares.
CMCSA Comcast
$34.93

0.9 (2.64%)

07/13/18
LOOP
07/13/18
NO CHANGE
Target $125
LOOP
Buy
Disney price target lowered to $125 from $130 at Loop Capital
Loop Capital analyst Alan Gould lowered his price target on Disney (DIS) to $125, saying the bidding process for 21st Century Fox (FOXA) and Sky (SKYAY) could see another increase by the company to low $40s per share and up to GBP 15 per share respectively. Gould believes that Disney will end up acquiring both assets, with associated costs lowering its EPS by 18c per share. Longer term, the analyst keeps his Buy rating on Disney, noting that despite its premium valuation, it has "carried an even higher multiple on a similar mid-teens EPS growth rate".
07/13/18
BERN
07/13/18
NO CHANGE
BERN
Bernstein 'not so sure' Comcast will give up on Fox assets
Bernstein analyst Todd Juenger said that it appears that the market is starting to believe Comcast (CMCSA) will give up on its bid to buy assets from 21st Century Fox (FOXA) and focus on Sky (SKYAY), but he said he is "not so sure" that is the case after only one counter from Disney (DIS). He does not believe Comcast would put forth a $35 bid unless it was prepared to bid up to near $45 per share, Juenger tells investors. If Comcast ups its bid, it either wins Fox at a high price or Disney is forced to pay more, which both seem better than giving up to him, Juenger stated. In any case, the "winner" will be left with increased leverage on a cyclical business late in the cycle at a time when it needs to invest significantly to build its direct-to-consumer business, added Juenger.
07/13/18
07/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VF CORP DOUBLE UPGRADE: BofA Merrill Lynch analyst Robert Ohmes upgraded VF Corp (VFC) to Buy from Underperform and raised his price objective to $96 from $65 ahead of the company's earnings report on July 20, telling investors in a research note that he believes Vans will be a "go-to-brand" for the back-to-school selling season. He said his channel checks indicate accelerating momentum in Vans, especially classic styles, and that the $50-$60 price point is attractive given consumers' shift to value. RAYMOND JAMES DOWNGRADES AT&T: Raymond James downgraded AT&T (T) to Market Perform from Outperform. Analyst Frank Louthan said he views the Department of Justice appeal of the Time Warner case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail. AT&T is lower by 2% in late morning trading. STIFEL STARTS GALMED WITH A BUY: Stifel analyst Adam Walsh initiated Galmed (GLMD) with a Buy rating and $35 price target, calling it a "legitimate late-stage NASH play" after Aramchol recently proved itself in a Phase 2 trial as a clearly active and "very safe" compound for treating NASH. Galmed is trading higher by over 17% in late morning trading. MORGAN STANLEY HIKES WWE TARGET TO $100: Morgan Stanley analyst Benjamin Swinburne said that WWE (WWE), by securing rights fees in its new five-year agreements with NBC (CMCSA, CMCSK) and Fox (FOX, FOXA) that are 3.6 times higher than its prior five-year broadcast agreement with NBC, has gained a "massive increase" in earnings power and "extremely high" visibility into the associated revenue. Given the recently announced deals, he raised his price target on WWE shares to $100 from $58 and kept an Overweight rating on the stock. WILLIAM BLAIR CALLS KEMPER PULLBACK 'BUYING OPPORTUNITY': William Blair analyst Adam Klauber said he views shares of Kemper (KMPR) as "even more attractive" after the recent pullback, which he attributes to selling pressures from Infinity Property shareholders receiving Kemper stock. Klauber said Kemper "continues to be our top conviction idea," and kept an Outpeform rating on the name. Kemper is higher by 4.8% in late morning trading.
07/10/18
FBCO
07/10/18
INITIATION
Target $36
FBCO
Neutral
Comcast initiated with a Neutral at Credit Suisse
Credit Suisse analyst Douglas Mitchelson initiated Comcast with a Neutral rating and a price target of $36. The analyst says the company has "terrific management and assets generating returns, but broadband is maturing and video & voice are in decline. Mitchelson adds that while the Street is still forecasting 5-6% EBITDA growth for years, investors are beginning to discount Comcast going "ex-growth" soon.
DOV Dover
$75.88

1.67 (2.25%)

05/10/18
STFL
05/10/18
NO CHANGE
Target $85
STFL
Hold
Dover price target lowered to $85 to account for Apergy spin at Stifel
After Dover (DOV) announced yesterday that it has completed the spin of its well site business known as Apergy (APY), Stifel analyst Nathan Jones adjusted his price target on Dover standalone shares to $85, down from $104, to reflect the completion of the spin. He maintains a Hold rating on Dover shares.
04/03/18
BOFA
04/03/18
NO CHANGE
BOFA
BofA/Merrill's Top 10 US Ideas for Q2 2018
BofA/Merrill introduced its Top 10 Ideas for Q2 2018. They are Buy rated Abbott (ABT), ADP (ADP),Coca-Cola European Partners (CCE), Discovery (DISCA), Dover (DOV), Lowe's (LOW), MGM Resorts (MGM), and Qualcomm (QCOM), and Underperform rated Ralph Lauren (RL) and BlackBerry (BB).
06/18/18
BMOC
06/18/18
NO CHANGE
Target $98
BMOC
Outperform
Dover price target lowered to $98 from $115 at BMO Capital
BMO Capital analyst R. Scott Graham lowered his price target on Dover to $98 but kept his Outperform rating. Graham says that after talks with the management, he believes 2018 remains on track with the company's guidance but more loaded toward the second half of the year given the less positive price-cost trend. The analyst still expects the second half to be stronger than the first half in Fluids and Refrigeration segments, but says that Engineered Solutions will face tougher comparisons. Graham also deems his prior view for share repurchases to be overly aggressive.
07/12/18
DBAB
07/12/18
INITIATION
Target $79
DBAB
Hold
Dover resumed with a Hold at Deutsche Bank
Deutsche Bank analyst Nicole DeBlase resumed coverage of Dover with a Hold rating and $79 price target. The rating is unchanged from Deutsche's prior coverage.

TODAY'S FREE FLY STORIES

NFLX

Netflix

$355.84

3.61 (1.02%)

, GOOG

Alphabet

$1,144.00

3.45 (0.30%)

13:08
05/24/19
05/24
13:08
05/24/19
13:08
Hot Stocks
Netflix to release 'Little Black Mirror' episodes on YouTube starting May 26 »

Netflix Latin America…

NFLX

Netflix

$355.84

3.61 (1.02%)

GOOG

Alphabet

$1,144.00

3.45 (0.30%)

GOOGL

Alphabet Class A

$1,148.10

3.22 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 06

    Jun

  • 19

    Jun

  • 19

    Jun

  • 25

    Jun

  • 27

    Oct

13:07
05/24/19
05/24
13:07
05/24/19
13:07
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 5/24 Baker-Hughes…

UAL

United Continental

$81.10

0.19 (0.23%)

, BA

Boeing

$356.58

6.01 (1.71%)

13:07
05/24/19
05/24
13:07
05/24/19
13:07
Periodicals
United extending Boeing 737 Max cancellations through August 3, CNBC reports »

United Airlines (UAL)…

UAL

United Continental

$81.10

0.19 (0.23%)

BA

Boeing

$356.58

6.01 (1.71%)

AAL

American Airlines

$29.41

-0.08 (-0.27%)

LUV

Southwest

$51.33

0.36 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 12

    Jun

  • 12

    Jun

  • 25

    Jul

  • 13

    Nov

BBY

Best Buy

$64.89

-0.9 (-1.37%)

, SSNLF

Samsung

$0.00

(0.00%)

13:04
05/24/19
05/24
13:04
05/24/19
13:04
Periodicals
Best Buy cancels preorders for Samsung's foldable phone, CNN reports »

Best Buy (BBY) is…

BBY

Best Buy

$64.89

-0.9 (-1.37%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 11

    Jun

BHGE

Baker Hughes

$22.28

-0.78 (-3.38%)

13:03
05/24/19
05/24
13:03
05/24/19
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 4 to 983 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$162.59

1.07 (0.66%)

13:02
05/24/19
05/24
13:02
05/24/19
13:02
Hot Stocks
Visa CFO Vasant Prabhu appointed company vice chairman »

Visa announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

EHC

Encompass Health

$59.22

-0.315 (-0.53%)

13:01
05/24/19
05/24
13:01
05/24/19
13:01
Hot Stocks
Encompass Health names Kim Sullivan chief human resources officer »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

IONS

Ionis Pharmaceuticals

$67.35

0.215 (0.32%)

, BIIB

Biogen

$229.80

0.75 (0.33%)

13:01
05/24/19
05/24
13:01
05/24/19
13:01
Hot Stocks
Ionis, Biogen slip after FDA approves Novartis' Zolgensma for SMA treatment »

Shares of Ionis…

IONS

Ionis Pharmaceuticals

$67.35

0.215 (0.32%)

BIIB

Biogen

$229.80

0.75 (0.33%)

NVS

Novartis

$87.21

2.75 (3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

XRT

S&P Retail Index SPDR

$41.58

-0.09 (-0.22%)

13:00
05/24/19
05/24
13:00
05/24/19
13:00
Options
Size four-way put spread in SPDR Retail Trust as shares extend losses »

Size four-way put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGNX

Regenxbio

$43.60

1.11 (2.61%)

, NVS

Novartis

$87.13

2.67 (3.16%)

12:53
05/24/19
05/24
12:53
05/24/19
12:53
Hot Stocks
Regenxbio up 6% after Novartis receives FDA approval for Zolgensma »

Regenxbio (RGNX) will…

RGNX

Regenxbio

$43.60

1.11 (2.61%)

NVS

Novartis

$87.13

2.67 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

NVS

Novartis

$87.04

2.58 (3.05%)

12:47
05/24/19
05/24
12:47
05/24/19
12:47
Hot Stocks
Novartis says wholesale acquisition cost of Zolgensma $2.125M »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TIVO

TiVo

$6.87

0.04 (0.59%)

12:45
05/24/19
05/24
12:45
05/24/19
12:45
Options
TiVo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

12:45
05/24/19
05/24
12:45
05/24/19
12:45
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

VWAGY

Volkswagen

$0.00

(0.00%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Appeals court rules in favor of Volkswagen diesel car owners, Reuters reports »

A German appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$56.30

0.85 (1.53%)

, WCG

WellCare

$267.57

-6.89 (-2.51%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Third Point confirms Centene stake to CNBC, says WellCare deal in best interest »

CNBC tweeted: "Third…

CNC

Centene

$56.30

0.85 (1.53%)

WCG

WellCare

$267.57

-6.89 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

, IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

12:40
05/24/19
05/24
12:40
05/24/19
12:40
Technical Analysis
On The Fly: ETF fund flow highlights »

Flows for the past week…

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

XLK

Technology Select Sector SPDR

$73.62

0.33 (0.45%)

SMH

Market Vectors Semiconductor

$100.37

0.23 (0.23%)

SOXX

iShares PHLX Semiconductor ETF

$180.13

0.06 (0.03%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$119.60

0.14 (0.12%)

EEM

iShares MSCI Emerging Markets ETF

$40.00

0.08 (0.20%)

XLU

Utilities SPDR

$59.99

0.07 (0.12%)

XLV

Health Care Select Sector SPDR

$89.56

0.17 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$126.65

0.46 (0.36%)

, CCOEY

Capcom

$0.00

(0.00%)

12:37
05/24/19
05/24
12:37
05/24/19
12:37
Hot Stocks
Microsoft says Project xCloud can stream more than 3,500 games »

Kareem Choudhry,…

MSFT

Microsoft

$126.65

0.46 (0.36%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

NVS

Novartis

$86.93

2.47 (2.92%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Hot Stocks
Novartis announces FDA approval for Zolgensma »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CNC

Centene

$55.37

-0.08 (-0.14%)

, WCG

WellCare

$273.18

-1.28 (-0.47%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Periodicals
Third Point thinks Centene should consider sale before buying WellCare, WSJ says »

Daniel Loeb's Third…

CNC

Centene

$55.37

-0.08 (-0.14%)

WCG

WellCare

$273.18

-1.28 (-0.47%)

HUM

Humana

$262.97

3.1 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 05

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

  • 13

    Nov

NVS

Novartis

$86.95

2.49 (2.95%)

12:31
05/24/19
05/24
12:31
05/24/19
12:31
Hot Stocks
Breaking Hot Stocks news story on Novartis »

Novartis announces FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

KNX

Knight-Swift

$29.75

-0.65 (-2.14%)

12:30
05/24/19
05/24
12:30
05/24/19
12:30
Options
Volatility play opened in Knight Transportation »

Volatility play opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 13

    Nov

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:27
05/24/19
05/24
12:27
05/24/19
12:27
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Activist Third Point has…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:26
05/24/19
05/24
12:26
05/24/19
12:26
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Third Point thinks…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

FLEX

Flex

$9.39

-0.08 (-0.84%)

12:25
05/24/19
05/24
12:25
05/24/19
12:25
Periodicals
Huawei phone assembler Flex stops production at China factory, NAR says »

Flex, Huawei's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$357.37

6.8 (1.94%)

12:23
05/24/19
05/24
12:23
05/24/19
12:23
Periodicals
SEC probing Boeing disclosures on grounded 737 Max, Bloomberg reports »

The SEC is investigating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.